SCHEMBL7128319

SCHEMBL7128319

CCCCCSCCCCCCCCCCBr

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.46
THRB P10828 2/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
BLM P54132 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CA2 P00918 1/20 0.45
TSHR P16473 1/20 0.42
FAAH O00519 4/20 0.41
CES1 P23141 4/20 0.41
PLA2G6 O60733 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
PRKD3 O94806 2/20 0.37
PRKCG P05129 2/20 0.37
PRKCB P05771 2/20 0.37
PRKCA P17252 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9862658 1.00 CES2 (0.46) CES2THRBGMNNTP53POLB
SCHEMBL14306294 0.95 CES2 (0.41) CES2THRBGMNNTP53POLB
SCHEMBL29492071 0.95 CES2 (0.46) CES2THRBGMNNTP53POLB
SCHEMBL11658097 0.92 CES2 (0.43) CES2THRBGMNNTP53POLB
SCHEMBL7132002 0.90 CES2 (0.37) CES2THRBGMNNTP53POLB
SCHEMBL10929907 0.90 CA2 (0.50) CES2THRBGMNNTP53POLB
SCHEMBL11096720 0.90 CA2 (0.50) CES2THRBGMNNTP53POLB
SCHEMBL24362145 0.86 THRB (0.57) CES2THRBGMNNTP53POLB
SCHEMBL199156 0.86 THRB (0.57) CES2THRBGMNNTP53POLB
SCHEMBL9580049 0.86 THRB (0.57) CES2THRBGMNNTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503938-B1 Treatment of estrogen related disease or tumor, including prostatic hyperplasia, breast cancer, endometrial carcinoma, anovulatory infertility, melanoma or osteoporosis SCHERING AKTIENGESELLSCHAFT (DE) 2003-01-07 US disclosed
US-6147105-A USE IN THE TREATMENT OF ESTROGEN-RELATED DISEASES SCHERING AKTIENGESELLSCHAFT (DE) 2000-11-14 US disclosed